Digestive System Adenocarcinoma — Trials

Digestive System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,067 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,373
Recruiting: 799
Ph III recruiting: 82
Growth YoY: +14.4%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (618)

clinicaltrialsPublishedShowing 1,001–1,004 of 1,004 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04099134	PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma(PaCaReg)	recruiting	—	5,000	University of UlmOTHER	1	Sep 25, 2019	clinicaltrials
NCT03686709	Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment	recruiting	N/A	20	University of TennesseeOTHER	1	Sep 27, 2018	clinicaltrials